Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang R Sperr

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Expert Review of Hematology|July 12, 2012
Diagnosis, progression patterns and prognostication in mastocytosisWolfgang R Sperr, Peter Valent
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
Haematologica|January 19, 2007
Rituximab for the treatment of acquired antibodies to factor VIIIWolfgang R Sperr, Klaus Lechner, Ingrid Pabinger
International Archives of Allergy and Immunology|March 29, 2002
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosisWolfgang R Sperr, Hans-Peter Horny, Peter Valent
Leukemia & Lymphoma|March 5, 2003
Tryptase a novel biochemical marker of acute myeloid leukemiaWolfgang R Sperr, Alexander W Hauswirth, Peter Valent
Leukemia & Lymphoma|August 9, 2005
CD 33 as a target of therapy in acute myeloid leukemia: current status and future perspectivesWolfgang R Sperr, Stefan Florian, Alexander W Hauswirth, et al.
Cancers|April 14, 2026
Serial Determinations of Molecular Aberrations in Patients with Acute Myeloid Leukemia During Treatment with Oral Decitabine/CedazuridineKlaus Geissler, Gabriele Benetka, Maximilian Prinz-Wohlgenannt, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2004
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasmsPeter Valent, Wolfgang R Sperr, Lawrence B Schwartz, et al.
Swiss Medical Weekly|June 1, 2025
Hereditary alpha-tryptasemia - a potential cause of severe anaphylactic reactions and a modifier of mast cell diseasesAxel Rüfer, Gerhard Müllner, Oliver Fuchs, et al.
Oncotarget|September 2, 2016
Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myelomaKatharina Blatt, Harald Herrmann, Gabriele Stefanzl, et al.
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Expert Review of Hematology|July 12, 2012
Diagnosis, progression patterns and prognostication in mastocytosisWolfgang R Sperr, Peter Valent
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
Haematologica|January 19, 2007
Rituximab for the treatment of acquired antibodies to factor VIIIWolfgang R Sperr, Klaus Lechner, Ingrid Pabinger
International Archives of Allergy and Immunology|March 29, 2002
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosisWolfgang R Sperr, Hans-Peter Horny, Peter Valent
Leukemia & Lymphoma|March 5, 2003
Tryptase a novel biochemical marker of acute myeloid leukemiaWolfgang R Sperr, Alexander W Hauswirth, Peter Valent
Leukemia & Lymphoma|August 9, 2005
CD 33 as a target of therapy in acute myeloid leukemia: current status and future perspectivesWolfgang R Sperr, Stefan Florian, Alexander W Hauswirth, et al.
Cancers|April 14, 2026
Serial Determinations of Molecular Aberrations in Patients with Acute Myeloid Leukemia During Treatment with Oral Decitabine/CedazuridineKlaus Geissler, Gabriele Benetka, Maximilian Prinz-Wohlgenannt, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2004
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasmsPeter Valent, Wolfgang R Sperr, Lawrence B Schwartz, et al.
Swiss Medical Weekly|June 1, 2025
Hereditary alpha-tryptasemia - a potential cause of severe anaphylactic reactions and a modifier of mast cell diseasesAxel Rüfer, Gerhard Müllner, Oliver Fuchs, et al.
Oncotarget|September 2, 2016
Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myelomaKatharina Blatt, Harald Herrmann, Gabriele Stefanzl, et al.
Pageof 28